City Therapeutics raises $200 million in upsized IPO
Statements (3)
- Bullish
City Therapeutics raised $200 million in an upsized US IPO
- Neutral
City Therapeutics is pricing an upsized initial public offering
- Neutral
City Therapeutics is targeting a $158 million initial public offering.